Cooper Companies | COO - Przychody Ze Sprzedaży





Obroty Zmiana Data
Abbott USD 11.16B 300M 2026-03
Align Technology USD 1.04B 10M 2026-03
AtriCure USD 141.2M 700K 2026-03
Avanos Medical USD 182.2M 1.3M 2026-03
Bausch Health Companies USD 2.5B 300M 2026-03
Baxter International USD 2.7B 270M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
Becton, Dickinson and Co. USD 4.7B 600M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
Cooper Companies USD 1.08B 57.4M 2026-03
Dentsply International USD 880M 81M 2026-03
Dexcom USD 1.19B 70M 2026-03
Edwards Lifesciences USD 1.65B 80M 2026-03
Globus Medical USD 759.85M 66.55M 2026-03
Haemonetics USD 346M 7.03M 2026-03
Inogen USD 74.93M 504K 2024-09
Insulet USD 761.7M 22.1M 2026-03
Integra LifeSciences USD 391.9M 43M 2026-03
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Medtronic USD 9.8B 800M 2026-03
Merit Medical Systems USD 381.9M 12M 2026-03
Novartis USD 13.11B 750M 2026-03
ResMed USD 1.4B 0 2026-03
STAAR Surgical USD 93.5M 145.9M 2026-03
Steris USD 1.59B 90M 2026-03
Stryker USD 6B 1.2B 2026-03
Tandem Diabetes Care USD 247.22M 43.18M 2026-03
Teleflex USD 548.3M 20.68M 2026-03
Utah Medical Products USD 9.04M 955K 2025-12
Zimmer Biomet Holdings USD 2.09B 150M 2026-03